List of works - Alejandra Castanon

ACOG Guidelines on Cervical Screening: A Step in the Right Direction

scientific article published on 01 January 2010

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years

scientific article published on 11 February 2014

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

scientific article

Cervical cancer is not just a young woman's disease

scientific article published on 15 June 2015

Cervical cytology and the diagnosis of cervical cancer in older women

scientific article

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

scientific article published on 14 January 2014

Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years

scientific article published on 02 July 2013

Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease

scientific article published on 08 November 2016

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review.

scientific article published on 24 October 2016

Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.

scientific article

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

scientific article

Evaluating cytology for the detection of invasive cervical cancer

scientific article published on 30 June 2015

Evidence of HPV vaccination efficacy comes from more than clinical trials

scientific article published on 09 July 2020

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

scientific article published on 07 March 2013

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

scientific article published on 27 May 2015

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

scientific article published in January 2009

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study

scientific article published on 29 September 2015

How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?

scientific article published on 12 June 2013

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.

scientific article published on 15 September 2016

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study

scientific article published on 30 August 2020

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

article

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

scientific article published on 20 April 2016

Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?

scientific article published on 09 April 2015

Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?

scientific article published on 13 December 2017

New strategies for human papillomavirus-based cervical screening

scientific article

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

scientific article

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study

scientific article published on 19 December 2017

Pregnancy outcomes after treatment for cervical intraepithelial neoplasia in a single NHS hospital

scientific article published in May 2013

Response to comment on 'Characteristics and screening history of women diagnosed with cervical cancer aged 20-29'

scientific article published on 28 August 2014

Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers

scientific article published on February 2012

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study

scientific article

Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium

scientific article published on 23 December 2015

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study

scientific article

Safe thresholds for hybrid capture 2 test in primary cervical screening ⬇️

scientific article published in the British Medical Journal

Screening and adenocarcinoma of the cervix

scientific article published in August 2009

Single negative colposcopy: is it enough to rule out high-grade disease?

scientific article

Survival from Cervical Cancer Diagnosed Aged 20-29 Years by Age at First Invitation to Screening in England: Population-Based Study

scientific article published on 28 July 2020

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries

scientific article published in March 2017

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme

scientific article published on 16 April 2020

The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus (HPV) Assay in comparison to the DNA-based Hybrid Capture 2 HPV Test in 2 consecutive screening rounds with a 6-year interval in Germany

article

What is the Right Age for Cervical Cancer Screening?

scientific article published on 01 January 2010

List of works by Alejandra Castanon

ACOG Guidelines on Cervical Screening: A Step in the Right Direction

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

Cervical cancer is not just a young woman's disease

Cervical cytology and the diagnosis of cervical cancer in older women

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years

Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review.

Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

Evaluating cytology for the detection of invasive cervical cancer

Evidence of HPV vaccination efficacy comes from more than clinical trials

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study

How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?

Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?

Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?

New strategies for human papillomavirus-based cervical screening

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study

Pregnancy outcomes after treatment for cervical intraepithelial neoplasia in a single NHS hospital

Response to comment on 'Characteristics and screening history of women diagnosed with cervical cancer aged 20-29'

Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study

Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study

Safe thresholds for hybrid capture 2 test in primary cervical screening ⬇️

Screening and adenocarcinoma of the cervix

Single negative colposcopy: is it enough to rule out high-grade disease?

Survival from Cervical Cancer Diagnosed Aged 20-29 Years by Age at First Invitation to Screening in England: Population-Based Study

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme

The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus (HPV) Assay in comparison to the DNA-based Hybrid Capture 2 HPV Test in 2 consecutive screening rounds with a 6-year interval in Germany

What is the Right Age for Cervical Cancer Screening?